|
KMID : 0811719970010050597
|
|
Korean Journal of Physiology & Pharmacology
1997 Volume.1 No. 5 p.597 ~ p.602
|
|
|
Cytochrome P45O 2El Activity in a Korean Population
|
|
Dou-Hyun Muhn
Ji-Min Chae/Jae-Yong Bahn/Hae-Jung Song/Hyung-Kee Kim/Jun-Tack Kwon/Dong-Ryul Sohn
|
|
|
Abstract
|
|
|
|
Cytochrome P450 2E1 (CYP2E1) is involved in the toxicity and carcinogenicity of a number of solvents and xenobiotics. Like the various types of oxidation pharmacogenetics, the activity of the enzyme shows a discernible interindividual and interethnic variation. However, no pharmacogenetic information on CYP2E1 polymorphism has been available from a Korean population. The aim of this study was to explore the pharmacogenetics of CYP2E1 polymorphism in a native Koreans after an oral 400 mg dose of chlorzoxazone administered to 128 subjects. Urine samples were collected during the subsequent 8-hour period and urinary concentrations of chlorzoxazone and 6-hydroxychlorzoxazone were determined by a high performance liquid chromatography with an ultraviolet detector. The limit of detection in the samples was found to be 0.5μg/ml. The mean value of the 6-hydroxychlorzoxazone excreted in 8 hr urine expressed as the percentage was 48.2 13.8%. The frequency distribution of percentage of the administered dose excreted as the 6-hydroxy metabolite was unimodally distributed in the subjects studied. However, the values showed wide (7-fold) interindividual difference, ranged from 11.6% to 79.8% of the dose of chlorzoxazone. Thus, it was considered that the pharmacogenetic characteristics of CYP2E1 in a Korean population did not represent multimodal distribution in the 6-hydroxychlorzoxazone excreted in 8-hr urine expressed as the percentage. And the activity of the CYP2E1 in a Korean population seemed to be less compared with that of the Caucasian subjects.
|
|
|
KEYWORD
|
|
|
Cytochrome P450 2El, Chlorzoxazone, Koreans,
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
  
|